The technological race between the United States and China intensifies as the U.S. imposes strict export controls on biotechnology. The Department of Commerce has implemented new rules aimed at safeguarding…
**A rough year for BRAIN Biotech has resulted in declining revenue and increasing net losses.** The company reported a revenue of €55.5 million for the fiscal year, reflecting a minor…
**Investment firm RTW Investments has launched a cutting-edge biotech venture named Prolium Bioscience, aimed at revolutionizing treatment for certain cancers.** With a strategic focus on a promising CD20×CD3 bispecific antibody,…
### Major Startup Funding Highlights This Week Investors are making waves in the startup ecosystem as 2024 starts off strong with significant funding rounds. This week continues to showcase major…
### BRAIN Biotech's Latest Performance Shakes Investor Confidence BRAIN Biotech AG (ETR:BNN) unveiled its annual report, revealing disappointing financial results. The company reported revenues of **€55 million**, falling short of…
Jiangsu Hengrui Pharmaceuticals Sets Global Aspirations In a recent presentation at the prestigious J.P. Morgan Healthcare Conference, Jiangsu Hengrui Pharmaceuticals showcased its ambitious plans to expand its influence beyond China.…
Important changes are coming to U.S. export laws! On Wednesday, the U.S. Department of Commerce revealed plans to impose new restrictions on the export of specific biotechnology equipment, driven by…
Evaxion Trajectory Shift Evaxion Biotech (NASDAQ: EVAX) has just implemented a significant change to its American Depositary Shares (ADS) ratio, set in motion from January 14, 2025. Previously, each ADS…
### A Peek Into the Biotech World As the J.P. Morgan Healthcare Conference unfolds in San Francisco, the atmosphere is charged not just with excitement but heightened security measures. A…
Telix Pharmaceuticals Takes a Bold Step Telix Pharmaceuticals has made a significant move in the biotech arena, announcing an acquisition deal with ImaginAb, a US-based biotech company. This strategic acquisition…